PalBociclib Impurity 23 химические свойства, назначение, производство
Использование
Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 3-Fluoro-2-nitropyridine (F597685).
PalBociclib Impurity 23 препаратная продукция и сырье
сырьё
препарат